4 Polen Capital GeneDx Holdings Trades
Polen Capital's position in GeneDx Holdings is currently worth $5.31M. That's 0.03% of their equity portfolio (57th largest holding). The first GeneDx Holdings trade was made in Q2 2025. Since then Polen Capital bought shares one more times and sold shares on two occasions. The investor's estimated purchase price is $6.22M, resulting in a loss of 15%.
Avg closing price
Price range
Increased shares by 29.3% (+17.6k shares)
Q1 2026
Avg closing price
$92.42
Price range
$57.09
-
$137.47
Sold 12.2% shares (-8.31k shares)
Q4 2025
Avg closing price
$137.70
Price range
$113.44
-
$167.52
Sold 15.8% shares (-12.8k shares)
Q3 2025
Avg closing price
$109.00
Price range
$77.87
-
$132.54
New holding (+81k shares)
Q2 2025
Avg closing price
$77.67
Price range
$56.36
-
$112.49
